Funding · Healthcare & Life Sciences

Redcliffe Lifetech raises $61 million Series B

What they do

Redcliffe Lifetech is an omnichannel diagnostics platform offering 3,500+ pathology and genetic tests

It raised $61 million in Series B funding led by LeapFrog Investments, with participation from Healthquad, Schroders, and others

The company plans to expand into tier 2, 3 and 4 cities and scale its platform to reach 500 million Indians in five years

Redcliffe Lifetech raised $61 million in a Series B funding round.
The round was led by LeapFrog Investments, a global impact investor.
Participating investors included Healthquad, Schroders, LC Nueva, and Growth Spark Ventures.
Existing investors Chiratae Ventures and Alkemi Venture Partners also participated.
The company will use the funds to expand into tier 2, 3 and 4 cities and scale its platform.
It also plans to increase product offerings in radiology, disease data profiling, and lifestyle management.
Redcliffe Lifetech aims to reach 500 million Indians within five years.

The diagnostics market in India is growing rapidly, especially in smaller cities.
Redcliffe offers tests at 25% to 60% lower prices than traditional competitors.
The company has already built a network of 22 labs across 14 cities and 500 offline collection centres.
It previously raised a $10 million Series A in 2021.

Redcliffe Lifetech is an omnichannel diagnostics platform offering over 3,500 pathology and specialised tests, including genetics.
It operates 22 labs across 14 cities, several NABL accredited, and has 500 offline collection centres.
The company has 400 phlebotomists operating in over 100 cities with home sample collection.
Its proprietary technology platform covers consumer experience, lab operations, fulfillment, and CRM.
Redcliffe has piloted drone technology for supply chain to reach smaller cities and remote areas.
It co-developed live remote temperature tracking for sample integrity during collection.
The website reports 1 crore+ lives touched, 80+ self-owned certified labs, 2,000+ collection centres, and 1,500+ trained phlebotomists.
It offers health checkup packages, smart reports with colour-coded insights, expert consultation, AI assistance, and diet plans.
Redcliffe also has Femcliffe Health Packages (India’s first she-centric diagnostic platform) and GeneCliffe for DNA, chromosome and protein insights.

Expand reach into tier 2, 3 and 4 cities.
Scale the platform and increase product offerings in radiology, disease data profiling, and lifestyle management.
Reach 500 million Indians within five years.

LeapFrog Investments (lead) — Global impact investor focused on healthcare and financial services in emerging markets.
Healthquad (participated) — Healthcare-focused investment firm.
Schroders (participated) — Global asset management company.
LC Nueva (participated) — Investment firm.
Growth Spark Ventures (participated) — Venture capital firm.
Chiratae Ventures (existing) — Indian venture capital firm investing in technology startups.
Alkemi Venture Partners (existing) — Venture capital firm.